Lyric Pharmaceuticals: Clinical Trials

1 trial sponsored by Lyric Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Lyric Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
Ulimorelin, Metoclopramide - Enteral Feeding Intolerance (EFI)
Phase 2CompletedLyric Pharmaceuticals1202016-10-012018-03-07

Interventions

Metoclopramide (1)  ·  ulimorelin (1)

Countries

Netherlands (1)  ·  Spain (1)  ·  United States (1)

Top investigators

M Scott Harris, MD (1)

NIH funding

2016 (1)